Desq Long
Sign in

Company

Kymera Therapeutics, Inc.

KYMR · CIK 0001815442

SEC FORM 4
$62,400.00

Kymera Therapeutics, Inc. (KYMR)

Acquisition (code M) of 30,000 shares at $2.08 per share.

Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →

SEC FORM 4
$392,826.00

Kymera Therapeutics, Inc. (KYMR)

Sale of 3,525 shares at $111.44 per share.

Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →

SEC FORM 4
$618,984.52

Kymera Therapeutics, Inc. (KYMR)

Sale of 5,506 shares at $112.42 per share.

Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →

SEC FORM 4
$552,158.24

Kymera Therapeutics, Inc. (KYMR)

Sale of 4,876 shares at $113.24 per share.

Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →

SEC FORM 4
$869,782.43

Kymera Therapeutics, Inc. (KYMR)

Sale of 7,601 shares at $114.43 per share.

Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →

SEC FORM 4
$949,742.00

Kymera Therapeutics, Inc. (KYMR)

Sale of 8,230 shares at $115.40 per share.

Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →

SEC FORM 4
$30,423.44

Kymera Therapeutics, Inc. (KYMR)

Sale of 262 shares at $116.12 per share.

Reporting Person Mainolfi Nello · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410839 · filed 2026-10-01 · View filing →

SEC FORM 4
$139,699.95

Kymera Therapeutics, Inc. (KYMR)

Sale of 1,209 shares at $115.55 per share.

Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →

SEC FORM 4
$353,350.25

Kymera Therapeutics, Inc. (KYMR)

Sale of 3,025 shares at $116.81 per share.

Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →

SEC FORM 4
$251,247.09

Kymera Therapeutics, Inc. (KYMR)

Sale of 2,137 shares at $117.57 per share.

Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →